Pharmaceuticals (TRBC)

Regeneron-Sanofi drug succeeds mid-stage study

Regeneron-Sanofi drug succeeds mid-stage study

Published 16/10/2017

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. [more…]

Exelixis drug improves overall survival in liver cancer patients

Exelixis drug improves overall survival in liver cancer patients

Published 16/10/2017

Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. [more…]

China to speed up drug approvals, will accept overseas trial data

China to speed up drug approvals, will accept overseas trial data

Published 09/10/2017

China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market. [more…]

Flexion`s knee pain drug gets FDA nod, shares hit life high

Flexion`s knee pain drug gets FDA nod, shares hit life high

Published 06/10/2017

Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday. [more…]

Fall is right time to rethink your Medicare drug plan options

Fall is right time to rethink your Medicare drug plan options

Published 05/10/2017

Forewarned is forearmed - and for U.S. seniors, the warning just arrived in the mail. [more…]

Senator Cruz opposes Republican healthcare bill, casting doubt on vote: Politico

Senator Cruz opposes Republican healthcare bill, casting doubt on vote: Politico

Published 24/09/2017

Republican U.S. Senator Ted Cruz on Sunday said he opposes the latest version of a Senate attempt to repeal Obamacare, casting doubt on the healthcare bill's chances of passage, Politico reported. [more…]

FDA declines to approve J&J arthritis drug sirukumab

FDA declines to approve J&J arthritis drug sirukumab

Published 22/09/2017

The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday. [more…]

Native American tribe moves to dismiss Allergan patent case

Native American tribe moves to dismiss Allergan patent case

Published 22/09/2017

A Native American tribe holding patents for drugmaker Allergan Plc (AGN.N) on Friday moved to dismiss a case brought by generic drug company Mylan NV (MYL.O) challenging the patents. [more…]

Costly drugs to weigh on U.S. employers` expenses in 2018: survey

Costly drugs to weigh on U.S. employers` expenses in 2018: survey

Published 18/09/2017

U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer. [more…]

Nabriva`s pneumonia drug succeeds in late-stage trial, shares soar

Nabriva`s pneumonia drug succeeds in late-stage trial, shares soar

Published 18/09/2017

Nabriva Therapeutics Plc shares more than doubled in premarket trading on Monday after the company said its experimental antibiotic for community-acquired bacterial pneumonia met the main goal of a late-stage study. [more…]